Isotopic Pattern Analysis for Mass Spectral Phenotypic Comparison
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for phenotypic comparison of biological organisms using stable isotopes are limited by their targeted analyses and inability to distinguish between analyte peaks from control and experimental samples, especially in complex spectral environments, leading to issues with ion suppression and noise interpretation.
Innovation Solution
A method involving the creation of composite samples with predetermined stable isotope ratios for mass spectral analysis, where the ratio of first to second isotopes is used to determine phenotypic similarity or dissimilarity by comparing the median isotopic ratio of analyte peaks, allowing for the identification of source compounds and minimizing experimental noise.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If targeted analysis with single isotope incorporation is used, then precision in understanding metabolic fate is improved, but the ability to distinguish between control and experimental sample peaks is lost
Solution Approach 1:
The patent segments the isotopic labeling approach by using multiple distinct isotopes (e.g., 13C, 15N, 18O) incorporated at different positions or in different proportions in control versus experimental samples. This segmentation allows each sample type to have a unique isotopic fingerprint, enabling clear distinction between control and experimental peaks in mass spectral data while maintaining precise metabolic fate tracking.
Solution Approach 2:
The patent applies local quality by incorporating isotopes at specific locations within molecules rather than uniformly throughout. By placing distinct isotopic labels at different molecular positions in control versus experimental samples, the method creates locally differentiated isotopic patterns that preserve both measurement precision and sample distinguishability.
2Quantity of substance
If complex mixture with multiple isotopically-distinct standards is prepared, then quantitation of multiple molecules is improved, but ion suppression and noise interpretation issues worsen
Solution Approach 1:
The patent extracts the essential information needed for quantitation by using a simplified dual-isotope approach rather than incorporating multiple isotopically-distinct standards. By taking out only the necessary isotopic differentiation (control vs. experimental labeling), the method reduces spectral complexity and minimizes ion suppression while retaining the ability to quantitate multiple molecules through ratio-based analysis.
Solution Approach 2:
The patent changes the isotopic composition parameters of the samples, specifically using different ratios or positions of 13C, 15N, or 18O isotopes in control versus experimental samples. This parameter change creates distinguishable mass spectral patterns that reduce noise and ion suppression issues while enabling simultaneous quantitation of multiple metabolites through isotopic ratio measurements.
3Object-affected harmful factors
If stable isotopes are used instead of radioactive isotopes, then safety and regulatory freedom are improved, but the ability to trace metabolic fate with high sensitivity is reduced
Solution Approach 1:
The patent uses composite isotopic labeling strategies combining multiple stable isotopes (13C, 15N, 18O) in specific combinations and ratios to enhance the sensitivity and precision of metabolic fate tracing. By creating composite isotopic patterns rather than relying on a single isotope, the method compensates for the lower sensitivity of stable isotopes compared to radioactive isotopes while maintaining safety and regulatory advantages.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables accurate identification of phenotypic similarity or dissimilarity by distinguishing between analyte peaks from control and experimental samples, reducing ion suppression and noise, and providing a reliable method for phenotypic comparison across various organisms.
Implementation Method 1
mass spectral data of a system containing a biological organism
Implementation Method 2
a stable isotope is incorporated into a specific molecule at a specific location. This isotopically-labeled molecule, or 'precursor', is fed to an in vivo organism
Implementation Method 3
the final measurement determines the exact concentration of the non-labeled material by comparison
Data Source
AI summary
A method for assaying phenotypic similarity or dissimilarity between organisms is disclosed in which a composite sample of admixed first and second samples is provided. The first, standard sample contains average concentrations of compounds of molecular mass less than about 1000 AMU present in the organism species. The second, assay sample contains compounds of having a similar molecular mass present in the organism whose phenotype is to be assayed. The constituents of both samples are (i) in a liquid medium and (ii) each compound of a sample has the same, first and second respective amounts of first and second stable isotopes of a first atom. The composite sample is mass spectroscopically analyzed for analytes, with the ratio of first to second isotope being determined for each analyte, along with a composite sample median ratio. The ratios for each analyte are compared to the median, with outlying ratios indicating dissimilarity.